Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study

ConclusionsThe lack of changes in DTI metrics in MS patients over 24 months possibly indicates a neuroprotective role of DMF. These findings provide additional evidence of the beneficial effect of DMF on MS‐related pathology.This article is protected by copyright. All rights reserved.

Source: European Journal of Neurology - January 5, 2018 Category: Neurology Authors: Robert Zivadinov, Jesper Hagemeier, Niels Bergsland, Eleonora Tavazzi, Bianca Weinstock ‐Guttman Tags: Original Article Source Type: research